Related Experiment Videos
Hematologic effects of a single dose of methylnitrosourea
Abstract:
The hematological effects of a single dose of 50 mg/kg Methylnitrosourea (MNU),administered i.v. to CBA/J mice, are described. Special emphasis was given to the number of pluripotent (CFUS) and granulocytic committed (CFUc) stem cells found in the bone marrow and spleen. In the peripheral blood a decreased number of reticulocytes, granulocytes, lymphocytes and thrombocytes was seen. This was followed by a rapid return of reticulocytes and a very slow return of thrombocytes. The bone marrow cellularity was below normal for at least 2 weeks with a markedly reduced number of lymphocytes. A rapid decrease in bone marrow and splenic CFUS and CFUc to 20-50% of control values was observed within 3 hours in mice injected with MNU. Seven days after MNU treatment, CFUS was about 10% of normal in both tissues. Contrary to this, CFUc had undergone significant regeneration. After 3 weeks CFUS returned to normal levels. At no stage could colony stimulating activity be detected in the serum.
Insights
Methylnitrosourea (MNU) significantly impacts hematopoietic stem cells in mice. MNU rapidly depleted pluripotent (CFUS) and committed (CFUc) stem cells, with slow recovery, especially for CFUS.
Area of Science:
- Hematology
- Toxicology
- Stem Cell Biology
Background:
- Methylnitrosourea (MNU) is a known genotoxic agent.
- Understanding MNU's impact on hematopoietic stem cells is crucial for assessing its toxicity.
- Hematopoiesis relies on pluripotent (CFUS) and committed (CFUc) stem cells in bone marrow and spleen.
Purpose of the Study:
- To investigate the hematological effects of a single Methylnitrosourea (MNU) dose in mice.
- To quantify changes in pluripotent (CFUS) and granulocytic committed (CFUc) stem cells post-MNU administration.
- To observe the recovery kinetics of peripheral blood cells and bone marrow cellularity.
Main Methods:
- Intravenous administration of a single 50 mg/kg dose of Methylnitrosourea (MNU) to CBA/J mice.
- Quantification of pluripotent (CFUS) and granulocytic committed (CFUc) stem cells in bone marrow and spleen.
- Analysis of peripheral blood cell counts (reticulocytes, granulocytes, lymphocytes, thrombocytes).
- Monitoring bone marrow cellularity and serum colony stimulating activity.
Main Results:
- A rapid decrease in peripheral blood cells including reticulocytes, granulocytes, lymphocytes, and thrombocytes was observed.
- Bone marrow and splenic CFUS and CFUc levels dropped to 20-50% of control values within 3 hours post-MNU.
- CFUS remained significantly reduced (around 10% of normal) at 7 days, while CFUc showed regeneration.
- Bone marrow cellularity was suppressed for at least 2 weeks, with a marked reduction in lymphocytes.
Conclusions:
- Single-dose MNU causes profound and rapid hematotoxicity in mice, affecting both stem cell populations and mature blood cells.
- Pluripotent stem cells (CFUS) exhibit slower recovery compared to committed stem cells (CFUc) after MNU exposure.
- The study highlights MNU's significant impact on hematopoiesis, with implications for understanding its toxicological profile.